The apparent dichotomy was reflected in a study by Sattler et al. where exogenous administration of rIL-33 exacerbated spontaneous colitis in Il10−/− mice, while concomitantly driving the expansion of a population of IL-10-producing B cells in wild-type mice. This evidence concerns the gene IL10 and colitis.